Original from: CNN
The Biden administration has been planning for how to get past the crisis phase of the Covid-19 pandemic and will stop buying vaccines, treatments and tests as early as this fall, White House Covid-19 Response Coordinator Dr. Ashish Jha said on Tuesday.
"One of the things we've spent a lot of time thinking about in the last many months -- and we're going to continue this work, and you'll hear more from the administration on this -- is getting us out of that acute emergency phase where the US government is buying the vaccines, buying the treatments, buying the diagnostic tests," Jha said at an event sponsored by the US Chamber of Commerce Foundation.
"I would like to get to a point where every adult in America who wants a vaccine can get one. I'm hopeful we will be there. We're not quite there yet in terms of how many vaccine doses we've been able to buy," he said.
Jha said the transition to commercialization is complicated. It involves regulatory issues, market dynamic issues and equity issues, but the administration is working carefully and thoughtfully to get it right.
"Right now, everybody can walk into a CVS and get a vaccine. I want to make sure that when we make this transition, we don't end up at a point where nobody can get a vaccine because we didn't get the transition right," he said.
He said it would be important for the government to continue to make investments in the development of the next generation of vaccines and in pandemic preparedness.
"But this business of day-to-day running of a pandemic, that needs to transition, and we're working very hard to make sure that transition is in a very orderly and transparent way so everybody sees it coming," he said.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.